Japan gives $85M to zap polio in Nigeria; Malaria-immune children help develop vaccine;

> Shareholders of synthetic vaccine maker Inovio ($INO) have approved a one-for-four reverse stock split. More

> A hepatitis B vaccine administered in infancy can protect a child through late adolescence, a study has shown. Report

> Japan has given Nigeria $85 million for polio eradication. More

> A startup trying to develop a free vaccine to end HIV and AIDS is using crowdsourcing to fund the project. Report

And Finally... A group of children in Tanzania who are naturally immune to malaria are helping scientists develop a new vaccine. More

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.